- Home
- PBYI
as 09-15-2025 3:19pm EST
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | LOS ANGELES |
| Market Cap: | 171.7M | IPO Year: | N/A |
| Target Price: | $7.00 | AVG Volume (30 days): | 684.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.97 | EPS Growth: | 434.29 |
| 52 Week Low/High: | $2.32 - $6.07 | Next Earning Date: | 11-06-2025 |
| Revenue: | $238,062,000 | Revenue Growth: | 8.63% |
| Revenue Growth (this year): | -4.18% | Revenue Growth (next year): | -4.39% |
Latest Puma Biotechnology Inc News
PBYI Breaking Stock News: Dive into PBYI Ticker-Specific Updates for Smart Investing
Business Wire
11 days ago
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Simply Wall St.
11 days ago
Are Strong Financial Prospects The Force That Is Driving The Momentum In Puma Biotechnology, Inc.'s NASDAQ:PBYI) Stock?
Zacks
2 months ago
Add These 4 Top-Ranked Liquid Stocks to Boost Portfolio Returns
Zacks
2 months ago
Are Investors Undervaluing Puma Biotechnology (PBYI) Right Now?
Zacks
3 months ago
Is Puma Biotechnology (PBYI) Stock Undervalued Right Now?
Zacks
3 months ago
Incyte Gets FDA Nod for the Expanded Use of Monjuvi in Lymphoma
Zacks
3 months ago
Should Value Investors Buy Puma Biotechnology (PBYI) Stock?
Simply Wall St.
3 months ago
With 57% ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) boasts of strong institutional backing
Compare PBYI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PBYI Puma Biotechnology Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.